{"version":"1.0","type":"link","title":"PD-L1 expression across urothelial carcinoma subtypes: A multicenter comparison of 22C3 and SP142 for clinical decision-making in the immunotherapy era.","author_name":"Cuadra JDP 외","author_url":"https://prs-insight.online/author/Cuadra%20JDP","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/166715","thumbnail_width":1200,"thumbnail_height":630}